Dr Jane Frances Mcgarrahan, PHD | |
600 Red Hill Rd, Aston, PA 19014-1201 | |
(215) 630-6228 | |
Not Available |
Full Name | Dr Jane Frances Mcgarrahan |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 600 Red Hill Rd, Aston, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407828502 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PS006515L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jane Frances Mcgarrahan, PHD 321 Apple Dr, Exton, PA 19341-2149 Ph: (215) 630-6228 | Dr Jane Frances Mcgarrahan, PHD 600 Red Hill Rd, Aston, PA 19014-1201 Ph: (215) 630-6228 |
News Archive
Online learning interventions and small group debriefings can improve medical residents' attitudes and communication skills toward patients with substance use disorders, and may result in improved care for these patients, according to a new study from the Perelman School of Medicine at the University of Pennsylvania and Drexel University College of Medicine published online in Academic Medicine.
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
Nordic Naturals, the industry leader in omega-3 fish oil, introduces Kenai Wild™ Alaskan Salmon Oil to address the growing demand for salmon oil supplementation and to ensure that consumers have a choice that has been third-party tested for heavy metals including, arsenic, cadmium, lead, and mercury, and other contaminants such as PCBs.
Patients with cirrhosis are at risk for developing portal hypertension that can lead to the formation, dilation, and rupture of esophageal varices. The annual incidence of esophageal varices is approximately 5% and one third of those will bleed.
› Verified 3 days ago